SureTrader SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

ONVO RSS Feed
Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade
Search This Board:
Last Post: 9/2/2015 10:52:52 PM - Followers: 301 - Board type: Free - Posts Today: 0
WELCOME TO THE ORGANOVO BOARD


 
     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.

COMPANY PROFILE via YouTube
http://www.youtube.com/watch?feature=player_embedded&v=-A-uH15bQZw

 
ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014


IR and Media Contacts:
Investor Relations Contact: ir@organovo.com
Media Contact: media@organovo.com

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994


For all the latest company information, details, news, please visit http://www.organovo.com

 
Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:

Science

Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.

 

World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  

 

NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods.

http://www.invetech.com.au/portfolio/life-sciences/3d-bioprinter-world-first-print-human-tissue/
http://techli.com/2012/07/organovo-bioprinting/#.
https://www.youtube.com/watch?v=1O3c3pUg0L8 (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ONVO
Current Price
Volume:
Bid Ask Day's Range
Wiki
ONVO News: Current Report Filing (8-k) 08/24/2015 05:30:05 PM
ONVO News: Quarterly Report (10-q) 08/10/2015 04:15:37 PM
ONVO News: Current Report Filing (8-k) 08/10/2015 04:08:18 PM
ONVO News: Organovo Reports First-Quarter Fiscal 2016 Financial Results and Corporate Highlights 08/10/2015 04:05:00 PM
ONVO News: Confidential Treatment Order (ct Order) 08/05/2015 11:15:17 AM
PostSubject
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#8716   Nice, timely article. BuckeyeStocks 09/02/15 10:52:52 PM
#8715   $90 million on their balance sheet, virtually no debt dshade 09/02/15 02:42:25 PM
#8714   Organovo’s Bioprinting Future Looks Bright — CEO Keith rookiecrd1 09/02/15 01:43:47 PM
#8713   You could sit in cash and watch it Ballgame 09/01/15 03:12:05 PM
#8712   Cash is king. Have fun with this madness. RallyTheMarket 09/01/15 02:10:11 PM
#8711   Must be a down day. Haven't heard from Ballgame 09/01/15 02:01:24 PM
#8710   And just like that another 10% haircut. I RallyTheMarket 09/01/15 01:24:02 PM
#8709   Appears to me that action over last several Alvie 08/31/15 09:38:06 PM
#8708   To you as well Ballgame 08/31/15 02:55:29 PM
#8707   I'm lovin' my top shelf Tequila trades. dadx4 08/31/15 02:28:25 PM
#8706   How am I looking today Rally? This beer Ballgame 08/31/15 01:38:01 PM
#8705   I like what I read in this article. Ballgame 08/28/15 10:15:35 PM
#8704   Same article Rayank posted on August 16th. Reads RallyTheMarket 08/28/15 12:35:13 PM
#8703   Nice plug for ONVO. Keep it coming. bettyfordallstar 08/28/15 06:11:32 AM
#8702   We hit $2.50! Only 28 days of .19 gains RallyTheMarket 08/27/15 04:39:43 PM
#8701   Speak for yourself Ballgame 08/27/15 12:22:57 PM
#8700   And still down for the year. Ugly. RallyTheMarket 08/27/15 12:22:42 PM
#8699   Whew? $5? That'd be a 150% gainer. Ballgame 08/27/15 12:22:06 PM
#8698   News is wishful thinking. How much longer to RallyTheMarket 08/27/15 12:21:22 PM
#8697   Next week will be some news. Ballgame 08/27/15 12:19:54 PM
#8696   Bout to fly off the handle here once Ballgame 08/27/15 12:19:12 PM
#8695   No news coming. Wishful thinking. RallyTheMarket 08/27/15 12:18:58 PM
#8694   No news coming. Wishful thinking. RallyTheMarket 08/27/15 12:18:58 PM
#8693   My beer money fund just keeps on growing. Ballgame 08/27/15 10:25:58 AM
#8692   Hope so. I'd love to see this baby Ballgame 08/26/15 09:24:03 PM
#8691   Healthy buying just before the close....news to come??? Alvie 08/26/15 04:42:03 PM
#8690   Short numbers at high end again. Blame Keith RallyTheMarket 08/26/15 02:35:31 PM
#8689   Can they cover on days the market is RallyTheMarket 08/26/15 10:34:01 AM
#8688   Question? Is the 11.2 days to cover bettyfordallstar 08/26/15 08:16:33 AM
#8687   New short numbers out. bettyfordallstar 08/26/15 07:32:42 AM
#8686   Just to get crushed the next month.. this adeezl 08/25/15 06:35:28 PM
#8685   Ha. That was good. Any money is good Ballgame 08/25/15 06:01:50 PM
#8684   I would be happy to post a link Windbag1014 08/25/15 05:31:14 PM
#8683   You asked a question. I gave an Windbag1014 08/25/15 05:29:09 PM
#8682   Beer money. Burp. I thought ONVO was "the RallyTheMarket 08/25/15 05:04:44 PM
#8681   $13 was due to a promotion at the RallyTheMarket 08/25/15 05:03:51 PM
#8679   I'm making some nice profits thus far. Ballgame 08/25/15 02:36:04 PM
#8678   Company is failing. Stock is failing. Shareholders losing RallyTheMarket 08/25/15 02:03:17 PM
#8677   I haven't heard you suggest easy. Windbag1014 08/25/15 01:58:17 PM
#8675   It was $0.25 away from $13 in November Windbag1014 08/25/15 01:48:40 PM
#8674   Yeah, let's avoid easy profits because a target RallyTheMarket 08/25/15 01:46:39 PM
#8662   Nah. U r looking at only today. I Ballgame 08/25/15 12:10:43 PM
#8661   Market up 350 points. ONVO down 3 percent. RallyTheMarket 08/25/15 11:47:19 AM
#8659   INSIDER BUYING: New insider filings for ONVO: ORGANOVO rayank 08/25/15 06:17:15 AM
#8658   8-K out: UNITED STATES rayank 08/24/15 06:55:16 PM
#8657   They also have the ability to forget very quickly Ballgame 08/24/15 05:58:45 PM
#8656   I guess to be an investor of ONVO RallyTheMarket 08/24/15 05:39:04 PM
#8654   What was that? Plus .18? Yup, correct Ballgame 08/24/15 05:25:26 PM
#8651   PPS below $2 and no one wants it. RallyTheMarket 08/24/15 04:48:02 PM
#8650   Plenty of cash if you don't need to RallyTheMarket 08/24/15 04:42:04 PM
PostSubject